Spider-Man No Way Home, the third movie starring Tom Holland as the web-slinger, this week got off to a blistering start in both the U.K. and U.S.
The film had an opening day box office of 7.6 million pounds ($10.1 million) in the U.K., The Hollywood Reporter said, citing the U.K. Cinema Association. That beat out No Time to Die on its opening day and was “the biggest opening day of all time for a Wednesday,” according to THR.
On Thursday, the movie generated $50 million in preview showings, according to Exhibitor Relations Co., which tracks box office data.
That was No. 3 all-time for U.S. preview showings, although an asterisk was involved — the preview showings began earlier than normal for Spider-Man No Way Home.
Still, the results are welcome news for both Sony, which has the rights to the character, and Marvel Studios, which since 2017 had made Spider-Man films with Sony.
Spider-Man No Way Home adopts a “multi-verse” approach featuring villains (and the actors who played them) from Sony-made Spider-Man films of the past. Also present is Dr. Strange (Benedict Cumberbatch), the Marvel sorcerer who appeared in one solo Marvel movie and two Marvel Avengers films.
Dr. Strange was created by artist Steve Ditko and his earliest stories were by Ditko and Stan Lee. The Lee-Ditko team also created Spider-Man.
Since Avengers: Endgame in 2019, Marvel has come out with movies featuring lesser-known characters, Shang Chi and the Eternals. Spider-Man is the most popular Marvel character but one Marvel Studios has to share with Sony.
The release of Spider-Man No Way Home also comes amid a surge in COVID-19 cases, including a new COVID variant. COVID had forced the delay of various movies, including No Time to Die.
Filed under: Comic book movies, James Bond Films | Tagged: Avengers: Endgame, Benedict Cumberbatch, Bond 25, Marvel Studios, No Time to Die, Sony, Spider-Man No Way Home, Stan Lee, Steve Ditko, Tom Holland |
The Spy Command 
Leave a Reply